Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 190 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

Spinal Muscular Atrophies Brazil

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue Phase 2 India
Malaysia
Singapore

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 2 Spain
France

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

Heart Failure Germany

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

Acute Kidney Injury Due to Sepsis Phase 2 Turkey
Canada

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Sjogrens Syndrome Phase 3 United States
France
Germany
Slovakia
Czech Republic
Bulgaria
Poland
Japan
Romania
Hungary
Austria
Guatemala
Australia
Taiwan
Israel
Spain
United Kingdom
Portugal
Italy
Argentina
Canada
View All

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC) Phase 1, Phase 2 France

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Phase 1 Switzerland
Spain
Netherlands
Israel
View All

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Chronic Inducible Urticaria Phase 3 United States
China
Japan
Israel
Canada
Hong Kong
Malaysia
Turkey
Australia
Korea, Republic of
Singapore
View All

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

Hypertension Japan